| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lantheus Holdings, Inc. | Chief Medical Officer | Common Stock | 9.08K | $750K | $82.63 | Jun 17, 2024 | Direct |
| Magenta Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 75K | Aug 1, 2022 | Direct | ||
| Lantheus Holdings, Inc. | Chief Medical Officer | Stock Option (right to buy) | 16.2K | Jun 17, 2024 | Direct | ||
| Cyteir Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14.2K | Feb 3, 2023 | Direct | ||
| CONSTELLATION PHARMACEUTICALS INC | Chief Medical Officer | Stock Options (Right to buy) | 0 | Jul 15, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LNTH | Lantheus Holdings, Inc. | Jun 17, 2024 | 2 | $750K | 4 | Jun 20, 2024 | Chief Medical Officer |
| LNTH | Lantheus Holdings, Inc. | May 28, 2024 | 0 | $0 | 3 | Jun 6, 2024 | Chief Medical Officer |
| CYT | Cyteir Therapeutics, Inc. | Feb 3, 2023 | 1 | $0 | 4 | Feb 7, 2023 | Director |
| MGTA | Magenta Therapeutics, Inc. | Aug 1, 2022 | 1 | $0 | 4 | Aug 1, 2022 | Chief Medical Officer |
| MGTA | Magenta Therapeutics, Inc. | May 17, 2022 | 1 | $0 | 4 | May 19, 2022 | Chief Medical Officer |
| CYT | Cyteir Therapeutics, Inc. | Feb 22, 2022 | 1 | $0 | 4 | Feb 24, 2022 | Director |
| MGTA | Magenta Therapeutics, Inc. | Feb 15, 2022 | 1 | $0 | 4 | Feb 17, 2022 | Chief Medical Officer |
| CYT | Cyteir Therapeutics, Inc. | Dec 15, 2021 | 1 | $0 | 4 | Dec 16, 2021 | Director |
| CYT | Cyteir Therapeutics, Inc. | Dec 15, 2021 | 0 | $0 | 3 | Dec 16, 2021 | Director |
| MGTA | Magenta Therapeutics, Inc. | Oct 1, 2021 | 1 | $0 | 4 | Oct 4, 2021 | Chief Medical Officer |
| MGTA | Magenta Therapeutics, Inc. | Oct 1, 2021 | 0 | $0 | 3 | Oct 4, 2021 | Chief Medical Officer |
| CNST | CONSTELLATION PHARMACEUTICALS INC | Jul 15, 2021 | 2 | $0 | 4 | Jul 19, 2021 | Chief Medical Officer |